Tenaya Therapeutics Inc (TNYA)
4.25
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
4.25
0.00 (0.00%)
After-Hours: 20:00
Tenaya Therapeutics Cash from Operations (Quarterly): -28.66M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -28.66M |
| December 31, 2023 | -21.92M |
| September 30, 2023 | -23.64M |
| June 30, 2023 | -26.22M |
| March 31, 2023 | -30.29M |
| December 31, 2022 | -22.68M |
| September 30, 2022 | -27.56M |
| June 30, 2022 | -25.43M |
| March 31, 2022 | -28.76M |
| Date | Value |
|---|---|
| December 31, 2021 | -16.35M |
| September 30, 2021 | -16.66M |
| June 30, 2021 | -12.02M |
| March 31, 2021 | -15.79M |
| December 31, 2020 | -10.40M |
| September 30, 2020 | -9.534M |
| June 30, 2020 | -7.274M |
| March 31, 2020 | -8.238M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-30.29M
Minimum
Mar 2023
-7.274M
Maximum
Jun 2020
-19.50M
Average
-21.92M
Median
Dec 2023
Cash from Operations (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 2.834B |
| Solid Biosciences Inc | -20.82M |
| Dyne Therapeutics Inc | -78.54M |
| Sana Biotechnology Inc | -65.63M |
| Prime Medicine Inc | -67.71M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -4.489M |
| Cash from Financing (Quarterly) | 46.77M |
| Free Cash Flow | -101.62M |
| Free Cash Flow Per Share (Quarterly) | -0.3609 |
| Free Cash Flow Yield | -31.59% |